BRAF inhibitors: research accelerates in wake of positive findings.
Vicki
V
Brower
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D009154:Mutation / Q000187:drug effects*; D048493:Proto-Oncogene Proteins B-raf / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology
D000970:Antineoplastic Agents; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf